Novartis AG
Research Novartis AG (NOVN) on Bullrun: market cap CHF 242.19B, P/E 23.8, dividend yield 3.0%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerNOVN
- ExchangeSW
- CountrySwitzerland
- SectorHealthcare
- IndustryDrug Manufacturers - General
- CurrencyCHF
- Market capCHF 242.19B
- P/E23.8
- Dividend yield3.0%
- Financial periodQ2 2026
- RevenueUSD 14.95B
- Net incomeUSD 3.26B
- Free cash flowUSD 5.12B
- Gross margin75.2%
Valuation Snapshot
latest market cap is CHF 242.19B; P/E is 23.8; dividend yield is 3.0%.
Peer valuation comparison
Latest P/E is 23.84x versus a Healthcare sector median of 24.46x (2.5% below).
Latest dividend yield is 2.99% versus a Healthcare sector median of 2.11% (41.7% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 56.67B | USD 13.98B | USD 15.24B | 75.8% | n/a | USD 11.44B | USD 35.38B | USD 46.13B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-23 | CHF 242.19B | 23.8 | 2.9% | 3.7 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 3.7 CHF, yield 3.0%.
About Novartis AG
Novartis AG researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally. The company offers Entresto, an angiotensin receptorneprilysin inhibitor to treat symptomatic chronic heart failure with reduced ejection fraction (HFrEF); Cosentyx to treat plaque psoriasis, pso riatic arthritis, ankylosing spondylitis, and nonradiographic axial spondy loarthritis; Kisqali, a selective oral cyclin dependent inhibitor of kinases 4 and 6 (CDK4/6);
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Novartis AG's market cap?
Novartis AG's market capitalization is CHF 242.19B.
What is Novartis AG's P/E ratio?
Novartis AG's price-to-earnings (P/E) ratio is 23.8.
Does Novartis AG pay a dividend?
Novartis AG has a dividend yield of 3.0%.
What does Novartis AG do?
Novartis AG researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally.